Skip to main content

Peer Review reports

From: Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study

Original Submission
29 Mar 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
12 May 2021 Reviewed Reviewer Report
18 May 2021 Reviewed Reviewer Report
16 Jul 2021 Author responded Author comments - Jiaming Qian
Resubmission - Version 6
16 Jul 2021 Submitted Manuscript version 6
2 Aug 2021 Author responded Author comments - Jiaming Qian
Resubmission - Version 7
2 Aug 2021 Submitted Manuscript version 7
13 Aug 2021 Author responded Author comments - Jiaming Qian
Resubmission - Version 8
13 Aug 2021 Submitted Manuscript version 8
22 Aug 2021 Reviewed Reviewer Report
15 Nov 2021 Author responded Author comments - Jiaming Qian
Resubmission - Version 9
15 Nov 2021 Submitted Manuscript version 9
Publishing
10 Dec 2021 Editorially accepted
4 Feb 2022 Article published 10.1186/s12876-021-02074-z

You can find further information about peer review here.

Back to article page